Methods for preventing and/or treating lysosomal storage disorders
US-8940766-B2 · Jan 27, 2015 · US
Compositions for preventing and/or treating degenerative disorders of the central nervous system
US9409862B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9409862-B2 |
| Application number | US-201314084131-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 19, 2013 |
| Priority date | Oct 19, 2009 |
| Publication date | Aug 9, 2016 |
| Grant date | Aug 9, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides novel compounds as well as compositions and methods using the same for preventing and/or treating degenerative disorders of the central nervous system. In particular, the present invention provides methods for preventing and/or treating Parkinson's disease.
First claim
Opening claim text (preview).
What is claimed: 1. A compound selected from the group consisting of: or a pharmaceutically acceptable salt, or solvate thereof. 2. A compound represented by the formula: or a pharmaceutically acceptable salt thereof. 3. A compound represented by the formula: or a pharmaceutically acceptable salt thereof. 4. A compound represented by the formula: or a pharmaceutically acceptable salt thereof. 5. A compound represented by the formula: or a pharmaceutically acceptable salt thereof. 6. A pharmaceutical composition comprising at least one compound of claim 1 and at least one pharmaceutically acceptable carrier. 7. The compound of claim 1 , which is represented by the formula: or a pharmaceutically acceptable salt thereof. 8. The pharmaceutical composition of claim 6 , wherein the compound is represented by the formula: or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
Drugs for disorders of the nervous system · CPC title
Anti-Parkinson drugs · CPC title
Non condensed piperidines, e.g. piperocaine · CPC title
- C07D211/46Primary
having a hydrogen atom as the second substituent in position 4 · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9409862B2 cover?
- The present invention provides novel compounds as well as compositions and methods using the same for preventing and/or treating degenerative disorders of the central nervous system. In particular, the present invention provides methods for preventing and/or treating Parkinson's disease.
- Who is the assignee on this patent?
- Amicus Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D211/46. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).